1-bromo-2-(but-3-en-1-yl)-4-fluorobenzene | 1256476-38-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-bromo-2-(but-3-en-1-yl)-4-fluorobenzene
• 英文别名: 4-(2-Bromo-5-fluorophenyl)-1-butene；1-bromo-2-but-3-enyl-4-fluorobenzene
• CAS: 1256476-38-6
• 化学式: C₁₀H₁₀BrF
• 分子量: 229.092
• InChiKey: KEGXVKOTRQMUCF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-bromo-2-(but-3-en-1-yl)-4-fluorobenzene 在 potassium tert-butylate 、 碘 、 magnesium 作用下， 以 四氢呋喃 、 异丁醇 、 异丙醚 为溶剂， 反应 49.35h， 生成 (S)-5‑fluoro-1-[4-(4-methoxyphenyl)butyl]-2,3-dihydro-1H-indene
  参考文献：
  名称：

  Catalytic Enantioselective Cyclization/Cross-Coupling with Alkyl Electrophiles

  摘要：

  As part of our ongoing effort to expand the scope of cross-coupling reactions of alkyl electrophiles, we have pursued a strategy wherein the nucleophilic coupling partner includes a pendant olefin; after transmetalation by such a substrate, if beta-migratory insertion proceeds faster than direct cross-coupling, an additional carbon carbon bond and stereocenter can be formed. With the aid of a nickel/diamine catalyst (both components are commercially available), we have established the viability of this approach for the catalytic asymmetric synthesis of 2,3-dihydrobenzofurans and indanes. Furthermore, we have applied this new method to the construction of the dihydrobenzofuran core of fasiglifam, as well as to a cross-coupling with a racemic alkyl electrophile; in the latter process, the chiral catalyst controls two stereocenters, one that is newly generated in a beta-migratory insertion and one that begins as a mixture of enantiomers.

  DOI：

  10.1021/ja500706v
• 作为产物：
  描述：

  2-溴-5-氟溴苄 、 烯丙基溴化镁 以 四氢呋喃 、 乙醚 为溶剂， 生成 1-bromo-2-(but-3-en-1-yl)-4-fluorobenzene
  参考文献：
  名称：

  金催化氧化偶联反应与芳基三甲基硅烷

  摘要：

  在对新型氧化金氧芳基化反应的持续研究中，发现芳基硅烷是有效的偶联伙伴，为分子内亲电芳香取代机制提供了进一步的证据。在提供与先前描述的硼酸方法的产率互补的产率的同时，三甲基硅烷的使用减少了对均偶联副产物的观察，并允许进行轻松的分子内偶联反应。

  DOI：

  10.1021/ol102194c

文献信息

• Pyrazolopyrimidine Macrocycles as Inhibitors of Human Immunodeficiency Virus Replication
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US20150232481A1

  公开（公告）日：2015-08-20

  The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for making and using these compounds in the treatment of HIV infection.

  该披露通常涉及到I式化合物，包括用于治疗人类免疫缺陷病毒（HIV）感染的组合物和方法。该披露提供了HIV的新型抑制剂，含有这些化合物的药物组合物，以及在治疗HIV感染中制备和使用这些化合物的方法。
• Synthesis of Five- and Six-Membered Benzocyclic Ketones through Intramolecular Alkene Hydroacylation Catalyzed by Nickel(0)/N-Heterocyclic Carbenes
  作者：Yoichi Hoshimoto、Yukari Hayashi、Haruka Suzuki、Masato Ohashi、Sensuke Ogoshi

  DOI：10.1002/anie.201206186

  日期：2012.10.22

  Getting some closure: Mechanistic studies supported the participation of an oxanickelacycle complex in the hydroacylation step of the title reaction, which proceeds without decarbonylation even in the absence of well‐known chelation assistance by heteroatoms.

  得到一些封闭：机理研究支持了氧杂环丙烷合成物参与标题反应的加氢酰化步骤，该步骤即使不存在众所周知的杂原子螯合辅助，也不会脱羰。
• [EN] MACROCYCLIC FLU ENDONUCLEASE INHIBITORS<br/>[FR] INHIBITEURS MACROCYCLIQUES D'ENDONUCLÉASE DE LA GRIPPE
  申请人：JANSSEN BIOPHARMA INC

  公开号：WO2020075080A1

  公开（公告）日：2020-04-16

  The present invention relates to macrocyclic pyridotriazine derivatives of formula (I) and the pharmaceutically acceptable salts, solvates or or polymorph thereof, and the use of such compounds as a medicament, in particular in the prevention and/or treatment of viral infections caused by viruses belonging to the Orthomyxoviridae famiIy. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the compounds, and to the compositions or preparations for use as a medicament, more preferably for the prevention or treatment of viral infections caused by viruses belonging to the Orthomyxoviridae family.

  本发明涉及公式（I）的大环吡啶三嗪衍生物及其药学上可接受的盐、溶剂化合物或多型体，以及将这些化合物作为药物的用途，特别是用于预防和/或治疗由属于Orthomyxoviridae家族的病毒引起的病毒感染。本发明还涉及药物组合物或混合制剂，以及用作药物的组合物或制剂，更偏好用于预防或治疗由属于Orthomyxoviridae家族的病毒引起的病毒感染。
• Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US09273067B2

  公开（公告）日：2016-03-01

  The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for making and using these compounds in the treatment of HIV infection.

  本公开涉及公式I的化合物，包括用于治疗人类免疫缺陷病毒（HIV）感染的组合物和方法。本公开提供了新型的HIV抑制剂，包含这些化合物的药物组合物，以及在治疗HIV感染中使用这些化合物的方法。
• Macrocyclic flu endonuclease inhibitors
  申请人：Janssen BioPharma, Inc.

  公开号：US11312727B1

  公开（公告）日：2022-04-26

  The present invention relates to macrocyclic pyridotriazine derivatives of formula (I) and the pharmaceutically acceptable salts, solvates or polymorph thereof, and the use of such compounds as a medicament, in particular in the prevention and/or treatment of viral infections caused by viruses belonging to the Orthomyxoviridae family. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the compounds, and to the compositions or preparations for use as a medicament, more preferably for the prevention or treatment of viral infections caused by viruses belonging to the Orthomyxoviridae family.

  本发明涉及式(I)的大环哒嗪衍生物及其药学上可接受的盐、溶解物或多晶型物，以及此类化合物作为药物的用途，特别是用于预防和/或治疗由属于正粘病毒科的病毒引起的病毒感染。本发明还涉及化合物的药物组合物或组合制剂，以及用作药物的组合物或制剂，更优选用于预防或治疗由属于Orthomyxoviridae科的病毒引起的病毒感染。